Alca-C, Brausetabletten - 10 Tablette(n) Swissmedic Key 33124015 Registration Holder Melisana AG Name Alca-C, Brausetabletten Date of registration 05.08.1974 Introduction of Sequence 05.08.1974 ATC-Classification Carbasalate Calcium Combinations Excl. Psycholeptics (N02BA65) Revision date 24.07.2007 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.01.20. Show package size 10 Tablette(n) Index Therapeuticus (Swissmedic) 01.01.20. Description Swissmedic categorie. D SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price 9.40 Feedback FB GTIN 7680331240158 Medication Code Synthetika Pharmacode Disponibility
Composition carbasalatum calcicum 528 mg corresp. acidum acetylsalicylicum 415 mg, acidum ascorbicum 250 mg, povidonum, acidum citricum, natrii citras dihydricus, natrii hydrogenocarbonas, acidum tartaricum, aromatica (Mandarine), aromatica (Orange) cum alcohol benzylicus 1.68 mg, saccharinum natricum, natrii cyclamas, E 101, E 120, pro compresso corresp. natrium 415.479 mg. Packungsbestandteile Galenic Form Effervescent tablets Active Agent Dose Ascorbic Acid 250 mg Carbasalate Calcium 528 mg correspond Acetylic Salicylic Acid 415 mg
Inactive agents Dose additional_information Citric Acid Tartaric Acid Aromatica (Mandarine) Aromatica (Orange) cum Alcohol Benzylicus 1.68 mg E 101 color. E 120 color. Natrii Citras Dihydricus Natrii Cyclamas Sodium Hydrogen Carbonate Povidone Pro Compresso Saccharinum Natricum
Source Data was imported : 07.03.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
